Provided by Tiger Fintech (Singapore) Pte. Ltd.

Applied Therapeutics Inc.

0.3540
-0.0110-3.01%
Post-market: 0.36300.0090+2.54%19:49 EDT
Volume:1.11M
Turnover:398.24K
Market Cap:50.12M
PE:-1.16
High:0.3706
Open:0.3610
Low:0.3540
Close:0.3650
Loading ...

Here’s Why Applied Therapeutics, Inc. (NASDAQ:APLT) Is Among the Best Diabetes Stocks to Buy Under $10

Insider Monkey
·
06 Jan

Top Calls on Wall Street: Pony AI, Thermo Fisher, Aclaris Therapeutics, and More

The Fly
·
23 Dec 2024

Top Premarket Decliners

MT Newswires Live
·
23 Dec 2024

William Blair Downgrades Applied Therapeutics to Market Perform From Outperform

MT Newswires Live
·
23 Dec 2024

Applied Therapeutics Cut to Market Perform From Outperform by William Blair

Dow Jones
·
23 Dec 2024

William Blair downgrades Applied Therapeutics (APLT) to a Hold

TIPRANKS
·
23 Dec 2024

Penny Stock Applied Therapeutics' FDA Troubles Trigger Investor Lawsuit, Shareholders Claim Deception Over Govorestat Clinical Data

Benzinga
·
21 Dec 2024

Applied Therapeutics Names John Johnson as Executive Chair, Les Funtleyder as Interim CEO

MT Newswires Live
·
20 Dec 2024

RBC Cuts Price Target on Applied Therapeutics to $1.50 From $4, Keeps Sector Perform, Speculative Risk

MT Newswires Live
·
20 Dec 2024

Applied Therapeutics CEO Shendelman Steps Down

Dow Jones
·
20 Dec 2024

BRIEF-Applied Therapeutics Appoints John H. Johnson As Executive Chairman

Reuters
·
20 Dec 2024

Applied Therapeutics Appoints John H. Johnson as Executive Chairman

THOMSON REUTERS
·
20 Dec 2024

Applied Therapeutics Inc - Les Funtleyder Appointed Interim CEO

THOMSON REUTERS
·
20 Dec 2024

Applied Therapeutics Inc - Funtleyder to Continue as CFO While Serving as Interim CEO

THOMSON REUTERS
·
20 Dec 2024

Applied Therapeutics Inc - Shoshana Shendelman Steps Down as CEO

THOMSON REUTERS
·
20 Dec 2024

Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors – Contact Levi & Korsinsky LLP

TIPRANKS
·
18 Dec 2024